NCT00002837View on ClinicalTrials.gov

High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

September 30, 1995

Primary Completion Date

January 31, 2002

Study Completion Date

January 31, 2002

Conditions

Breast Cancer

Interventions

BIOLOGICAL

Filgrastim (G-CSF)

DRUG

Cyclophosphamide

DRUG

Doxorubicin Hydrochloride

DRUG

Paclitaxel

PROCEDURE

Peripheral Blood Stem Cell Transplantation

Trial Locations (1)

77030

University of Texas - MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER